Company Filing History:
Years Active: 2018-2020
Title: Guojun Wu: Innovator in Cell Reprogramming Technologies
Introduction
Guojun Wu is a notable inventor based in Northville, MI (US), recognized for his contributions to the field of cell reprogramming. He holds 2 patents that focus on innovative methods for treating diseases through advanced cellular techniques. His work aims to revolutionize the way we approach cancer treatment and cellular regeneration.
Latest Patents
Wu's latest patents include methods, systems, and compositions relating to cell conversion via protein-induced in-vivo cell reprogramming. These methods provide a pharmaceutical composition that includes a protein transduction reagent-modified reprogramming protein. The protein transduction reagent is non-covalently bound to the reprogramming protein and comprises a cation reagent and a lipid. This innovative approach allows for the delivery of modified reprogramming proteins to cancer cells and diseased tissues, facilitating the conversion of these cells into normal cells without the need for nucleic acid administration.
Career Highlights
Throughout his career, Guojun Wu has worked with esteemed institutions such as Wayne State University and Qurgen, Inc. His experience in these organizations has significantly contributed to his expertise in the field of cellular reprogramming and therapeutic applications.
Collaborations
Wu has collaborated with notable colleagues, including Jianjun Wang and Qianqian Li. These partnerships have fostered a collaborative environment that enhances innovation and research in cell reprogramming technologies.
Conclusion
Guojun Wu's work in cell reprogramming represents a significant advancement in medical science. His innovative patents and collaborations highlight his commitment to improving treatment options for patients with cancer and other diseases.